Results 191 to 200 of about 146,949 (323)

SARCOPENIA – CAUSES AND MANAGEMENT [PDF]

Vladimir Antić, Milorad Antić
openalex   +1 more source

Availability and use of dual energy X‐ray absorptiometry (DXA) and bio‐impedance analysis (BIA) for the evaluation of sarcopenia by Belgian and Latin American geriatricians [PDF]

, 2014
Everardo Treviño-Aguirre, Teresa López-Teros, Luis Miguel Gutiérrez‐Robledo, M. Vandewoude, Mario Ulises Pérez‐Zepeda   +4 more
openalex   +1 more source

Effectiveness and adherence in a tirzepatide‐supported digital weight‐loss programme in Australia: A real‐world observational study

Diabetes, Obesity and Metabolism, EarlyView.
Abstract Aims Obesity is a growing global health crisis; pharmacotherapies such as tirzepatide combined with multidisciplinary lifestyle support have shown promise but real‐world evidence in digital weight‐loss services (DWLSs) is limited. This retrospective study evaluated 6‐ and 12‐month weight loss, adherence and predictors of outcomes in an ...
Louis Talay, Jason Hom, Tamara Scott, Neera Ahuja   +3 more
wiley   +1 more source

How Pragmatic Are Sarcopenia Intervention Studies? A Systematic Review. [PDF]

J Cachexia Sarcopenia Muscle
Van Heden S, Baoubbou Z, Sanchez-Rodriguez D, Chan YM, Beaudart C.   +4 more
europepmc   +1 more source

Comparative effectiveness of pharmacotherapy for heart failure with preserved ejection fraction: A systematic review and network meta‐analysis

Diabetes, Obesity and Metabolism, EarlyView.
Abstract Aim Heart failure with preserved ejection fraction (HFpEF) presents a therapeutic challenge, characterised by a paucity of validated treatments. Emerging data suggest that targeting adiposity is central to HFpEF pathogenesis. We conducted an updated network meta‐analysis to compare the efficacy of emerging and established HFpEF therapies ...
Szu‐Han Chen, Yu‐Wen Tseng, Chi‐Jung Huang, Shu‐Mei Yang, Marat Fudim, Shao‐Yuan Chuang, Shih‐Hsien Sung, Hao‐Min Cheng   +7 more
wiley   +1 more source

Calprotectin Is a Circulating Biomarker and Potential Therapeutic Target for Sarcopenia in Chronic Obstructive Pulmonary Disease. [PDF]

J Cachexia Sarcopenia Muscle
Liao L, Li J, Xu W, Yin Y, Wang Z, Li C, Li Y, Zhou X, Deng M, Hou G.   +9 more
europepmc   +1 more source

Amino Acid Kinetics and the Response to Nutrition in Patients with Cancer [PDF]

, 2019
Deutz, Nicolaas Ep, Engelen, Marielle Pkj, Teleni, Laisa, van der Meij, Barbara S   +3 more
core   +1 more source

Advancing Sarcopenia Diagnosis and Treatment: Recommendations from the Taiwan Advisory Panel for Sarcopenia

Li‐Ning Peng, Ding‐Cheng Chan, Der‐Sheng Han, Chun-Ying Lee, Hao-Jan Lei, Wen‐Yuan Lin, T.W. Liu, Hsiang-Ju Pan, Chih‐Hsing Wu, Chi‐Hua Yen, Liang‐Kung Chen, Taiwan Advisory Panel for Sarcopenia (TAPS)   +11 more
openalex   +1 more source

Reference values of the dorsal muscle group area for the diagnosis of sarcopenia using chest computed tomography in patients with chronic obstructive pulmonary disease: A prospective observational study [PDF]

Manabu Ono, Seiichi Kobayashi, Masatsugu Ishida, Hikari Sato, Koji Okutomo, Masaru Yanai   +5 more
openalex   +1 more source

Impact of sarcopenia on outcomes of patients undergoing liver resection for hepatocellular carcinoma

, 2022
Jinhuan Yang, Kaiwen Chen, Chongming Zheng, Kaiyu Chen, Jian Lin, Qishan Meng, Ziyan Chen, Liming Deng, Haitao Yu, Tuo Deng, Zhiyuan Bo, Qikuan He, Yi Wang, Gang Chen   +13 more
openalex   +1 more source